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Evaluation of gut modulatory and bronchodilator
activities of Amaranthus spinosus Linn.
Mueen Ahmad Chaudhary1, Imran Imran1, Samra Bashir1,2*, Malik Hassan Mehmood2, Najeeb-ur Rehman2
and Anwarul-Hassan Gilani2
Abstract
Background: The aqueous-methanolic extract of Amaranthus spinosus (A. spinosus Linn.,) whole plant, was studied
for its laxative, spasmolytic and bronchodilator activities to validate some of its medicinal uses.
Methods: The crude extract of A. spinosus was studied in-vivo for bronchodilator and laxative activities and in-vitro
using isolated tissue preparations which were mounted in tissue baths assembly containing physiological salt
solutions, maintained at 37°C and aerated with carbogen, to assess the spasmolytic effect and to find out the
possible underlying mechanisms.
Results: In the in-vivo experiments in mice, the administration of A. spinosus increased fecal output at doses of 100
and 300 mg/kg showing laxative activity. It also inhibited carbachol-induced bronchospasm in anesthetized rats at
1, 3, 10 and 30 mg/kg indicative of bronchodilator activity. When tested on isolated gut preparations, the plant
extract showed a concentration-dependent (0.01-10.0 mg/ml) spasmogenic effect in spontaneously contracting
rabbit jejunum and guinea-pig ileum. The spasmogenic effect was partially blocked in tissues pretreated with
atropine (0.1 μM). When tested on K+ (80 mM)-induced sustained contractions in isolated rabbit jejunum, the plant
extract caused complete relaxation and also produced a shift in the Ca++ concentration-response curves (CRCs)
towards right, similar to diltiazem. In rabbit trachea, the plant extract completely inhibited K+ (80 mM) and
carbachol (CCh, 1 μM)-induced contractions at 1 mg/ml but pretreatment of tissue with propranolol (1 μM), caused
around 10 fold shift in the inhibitory CRCs of the plant extract constructed against CCh-induced contraction. The
plant extract (up to 0.3 mg/ml) also increased both force and rate of spontaneous contractions of isolated
guinea-pig atria, followed by relaxation at higher concentration (1.0-5.0 mg/ml). The cardio-stimulant effect was
abolished in the presence of propranolol, similar to that of isoprenaline. Activity-directed fractionation revealed that
the spasmolytic component(s) was separated in the organic fraction, whereas the spasmogenic component was
concentrated in the aqueous fraction.
Conclusion: These results indicate that A. spinosus possesses laxative activity partially mediated through cholinergic
action. The spasmolytic effect was mediated through calcium channel blocking (CCB), while bronchodilator activity
through a combination of β-adrenergic and CCB pathways, which may explain the traditional uses of A. spinosus in
gut and airways disorders.
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Background
Amaranthus spinosus Linn. (Family, Amaranthaceae),
commonly known as Prickly amaranth and locally in
Paksitan as Khaddar-chaulai, is a spinous weed culti-
vated throughout tropical and subtropical countries for
its use as vegetable and also as an animal feed [1,2]. The
plant is highly nutritive due to the presence of fibre, pro-
teins and high concentration of essential amino acids,
especially lysine [3]. Besides its culinary value, it is a
popular medicinal plant reputed for antipyretic,
appetizer, diuretic, febrifuge, galactagogue, haematinic,
laxative and stomachic effects and as a treatment for
hallucination, leprosy, eczema and piles [2]. It is also
useful in bronchitis, leucorrhoea, menorrhagia, boils,
burns, nausea, flatulence and colic [4], healing of
wounds and rheumatism [5], and to arrest the coughing
up of blood [6]. All parts of the plant are known to con-
tain medicinally active constituents [1].
Different studies have evaluated A. spinosus for the
presence of antioxidant [7], antinociceptive [8], hepato-
protective [9], anti-diabetic, anti-hyperlipidemic, sper-
matogenic [10] and antimalarial [11] activities.
Phytochemical studies revealed that the plant contains
alkaloids, flavonoids, glycosides, phenolic acids, steroids,
amino acids, terpenoids, lipids, saponins, betalains,
β-sitosterol, stigmasterol, linoleic acid, rutin, catechuic
tannins and carotenoids [9]. The betalains in stem bark
of A. spinosus were identified as amaranthine, isoamar-
anthine, hydroxycinnamates, quercetin and kaempferol
glycosides [11-15]. It also contains amaranthoside, a lig-
nan glycoside, amaricin, a coumaroyl adenosine along
with stigmasterol glycoside, betaine such as glycinebe-
taine and trigonelline [16,17].
Despite the wide medicinal uses of A. spinosus, no data
are available with respect to its effectiveness in gut mo-
tility and airways disorders. The present study on the
crude extract of A. spinosus and its fractions was under-
taken to rationalize these traditional uses and to explore
mechanistic basis for these medicinal uses.
Methods
Plant material
Fresh whole plant of A. spinosus Linn. was collected from
the fields of Bahauddin Zakariya University Multan,
Pakistan, and was identified by an expert taxonomist of
the Institute of Pure and Applied Biology, Bahauddin
Zakariya University, Multan. A specimen is deposited in
Herbarium of the Institute (voucher # Fl.P.231-2).
Preparation of crude extract and fractions
Following shade drying, the plant material was manually
made free from soil and other adulterants and was
ground to coarse powder by an electrically driven mill.
Approximately 400 g powdered plant material was
soaked in 70% aqueous-methanol by cold maceration at
room temperature for 7 days with occasional shaking
[18]. It was filtered through a double layered muslin
cloth and subsequently through a filter paper. The resi-
due was re-soaked in the fresh solvent and the process
was repeated thrice to get maximum yield of crude
extract from the plant material. The combined filtrate
was concentrated in rotary evaporator at 40°C under
reduced pressure (−760 mmHg) to a thick, semi-solid
mass, the crude extract of A. spinosus whole plant
(As.Cr), weighing 44.52 gm with approximated yield of
11.13%. A. spinosus was transfer to a glass bottle and
stored at −20°C until used. The stock solutions of
A. spinosus were prepared in distilled water and the dilu-
tions were made fresh in normal saline on the day of
experiment.
For the purpose of fractionation, 10 gm of the crude
extract was dissolved in water and shaken with ethyl
acetate in a separating funnel. Two layers of the im-
miscible solvents were allowed to separate. The ethyl
acetate layer was collected whereas the aqueous layer
was re-extracted with fresh ethyl acetate for a total of
three times. The ethyl acetate layers, so collected, were
combined and then dried on a rotary evaporator to
yield the ethyl acetate fraction (As.EtAc) weighing
0.3 gm. The aqueous layer left after extraction with
ethyl acetate was evaporated separately to obtain the
aqueous fraction (As.Aq) weighing 9.7 gm. Approxi-
mate yields of As.EtAc and As.Aq were 3% and 97% of
the crude extract, respectively. The As.EtAc was solubi-
lized by the following method; a solution of Tween-80
(100 mg/ml in ethyl acetate) was prepared, and 0.1 ml
of this solution was added to the solution of As.EtAc
(300 mg/ml) in ethyl acetate and shaken. The solvent
was then evaporated on a hot plate and the resultant
extract was suspended in water (1 ml) by vigorous
shaking. The concentration of this stock is considered
as 300 mg/ml [19].
Drugs and reagents
All the chemicals used in the experiments were of
highest purity and research grade and were obtained
from the sources specified: acetylcholine chloride,
atropine sulfate, aminophylline, carbachol, diltiazem,
histamine, isoprenaline, pyrillamine, potassium chloride
and phenylephrine from Sigma Chemicals Co. St Louis,
MO, USA, calcium chloride, glucose, magnesium
chloride, magnesium sulphate, potassium dihydrogen
phosphate, sodium bicarbonate, sodium dihydrogen
phosphate and methanol from Merck, Darmstadt,
Germany, and ammonium hydroxide, sodium chloride
and sodium hydroxide from BDH Laboratory Supplies,
Poole, England.
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Animals
Rabbits (1.0-1.5 kg), guinea-pigs (500-600 g) and BALB/c
mice (20-30 g) of local breed and either sex, used for the
experimental work, were housed under controlled environ-
mental condition (23-25°C) at the Animal House of Aga
Khan University, Karachi. Animals were given standard diet
and tap water. Animals were kept at fasting 24 h prior to
the experiments but had free access to water. Rabbits and
guinea-pigs used for in-vitro study were sacrificed by blow
on the back of head and cervical dislocation, respectively.
Mice were used for the in-vivo laxative activity. Experi-
ments performed complied with the rulings of Institute of
Laboratory Animal Resources, Commission on Life
Sciences [20] and approved by the Ethical Committee of
the Aga Khan University.
In-vivo experiments
Laxative activity
Mice were used as experimental animals to study the
laxative activity of A. spinosus in comparison with car-
bachol, by following a previously described method
[21]. The food supply was restricted to the mice 24 h
prior to the experiment but there was a free access to
water. The animals, kept individually in cages lined with
clean blotting sheets, were divided into five groups con-
taining five mice each to receive different treatments,
orally. Group 1, taken as the negative control, was
administered with normal saline (10 ml/kg), Group 2,
the positive control group, was administered with car-
bachol (1 mg/kg), while the Groups 3, 4 and 5, the test
groups, received 100, 300 & 500 mg/kg of the crude ex-
tract of A. spinosus, respectively. All five groups were
monitored for 18 h; total number of feces was counted
for each mouse and the average number of feces was
calculated for each group.
Effect on CCh-induced bronchospasm
Rats were anaesthetized with sodium thiopental (Pentothal,
80–100 mg/kg, i.p.) and underwent endotracheal intub-
ation followed by ventilation with a volume ventilator
(Miniature ideal pump, Bioscience, UK) adjusted at a rate
of 70–80 strokes/min to deliver 7–10 ml/kg of room air
[22]. A polyethylene catheter was inserted into the jugular
vein for drug administration. The changes in airways resist-
ance (mmHg) were measured by a pressure transducer
(MLT-1199) connected to PowerLab 4/25 with running
chart software via Quad bridge amplifier (AD Instruments,
Bella Vista, NSW, Australia). Bronchoconstriction was
induced with CCh (100 μg/kg), which was reversed within
7–10 min. The test drug was given to the animals 5–8 min
prior to administration of CCh. The responses were
expressed as the percent reduction of the CCh-induced
bronchospasm [22].
In-vitro experiments
The in-vitro experiments were performed according to
the protocols as previously described [23-25].
Rabbit jejunum
Plant extract was screened for its spasmogenic and spas-
molytic activities on isolated rabbit jejunum. Segments
of approximately 2 cm length were suspended in a 10 ml
tissue bath containing Tyrode’s solution having the fol-
lowing composition in mM: KCl 2.68, NaCl 136.9,
MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42, CaCl2 1.8
and glucose 5.55, aerated with carbogen (95% O2 and 5%
CO2) and maintained at 37°C. Each tissue was given 1 g
pretension, allowed to equilibrate for at least 30 min and
stabilized with the repeated exposure to 0.3 μM acetyl-
choline, ACh (3–5 times) and subsequent washing with
the Tyrode’s solution until the sub-maximal responses of
equal amplitude were obtained. The dose–response
curves of acetylcholine were constructed before the
addition of test materials. Maximum response of the tis-
sue to acetylcholine was considered to have been
achieved when the next higher concentrations of the
agonist failed to produce a further increase in response
[26]. The contractile effect of the test materials was
assessed as percent of the maximum effect produced
by the control drug, ACh. Intestinal responses were
obtained isotonically using BioScience transducers and
Powerlab data acquisition system (AD Instruments,
Sydney, Australia) attached to a computer installed with
Labchart software (version 6).
Determination of Ca++ antagonist effect
To assess whether the relaxant effect of the crud extract
was through calcium channel blocking activity, K+
(80 mM) was used to depolarize the preparations as
described by Farre et al. [27]. K+ (80 mM) was added to
induce the sustained contraction. The crud extract was
then added to the tissue bath in a cumulative fashion to
obtain concentration-dependent inhibitory responses
[28]. The relaxation of intestinal preparations, pre-
contracted with K+ (80 mM) was expressed as percent of
the control response mediated by K+. To confirm the
calcium antagonist activity of the crud extract, the tissue
was allowed to stabilize in normal Tyrode’s solution,
which was then replaced with Ca++-free Tyrode’s solu-
tion containing EDTA (0.1 mM) for 30 min in order
to remove Ca++ from the tissues. This solution was fur-
ther replaced with K+-rich and Ca++-free Tyrode’s solu-
tion, having the following composition in mM: KCl 50,
NaCl 91.04, MgCl2 1.05, NaHCO3 11.90, NaH2PO4 0.42,
glucose 5.55 and EDTA 0.1. Following an incubation
period of 30 min, control concentration–response curves
of Ca++ were constructed. When the control CRCs of
Ca++ were found super-imposable (usually after two
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cycles), the tissue was pretreated with the crude extract
for 50 min to test the possible calcium channel blocking
effect. The CRCs of Ca++ were reconstructed in the
presence of different concentrations of the test material,
diltiazem was used as a positive control.
Guinea-pig ileum
The ileum was dissected out and segments of approxi-
mately 2 cm length were suspended individually in a
10 ml tissue bath, filled with Tyrode’s solution and aera-
ted with carbogen at 37°C [29]. A preload of 1 g was ap-
plied to each tissue and kept constant throughout the
experiment. Following an equilibration period of 30 min,
isotonic contractions to ACh (0.3 μM) were repeated to
stabilize the preparation. The stimulant effect of the ex-
tract was determined on the resting baseline of the tis-
sue and was assessed as percent of the maximum effect
produced by the reference drug, ACh.
Rabbit trachea
Trachea was dissected out, cleaned free from the sur-
rounding fatty tissues and cut into rings having 2–3 mm
width (containing 2 cartilages). Each ring was then cut
longitudinally on the site opposite to the smooth muscle
layer in such a way that smooth muscles were in be-
tween the C-shaped cartilaginous part. The isolated pre-
parations were then mounted in a 15 ml tissue bath
containing Kreb’s solution having the following compos-
ition in mM: NaCl 118.2, NaHCO3 25.0, CaCl2 2.5, KCl
4.7, KH2PO4 1.3, MgSO4 1.2 and glucose 11.7, aerated
with carbogen at 37°C. The mounted tissue preparations
were given 1 g pre-tension and equilibrated for 1 h be-
fore the addition of any chemical substance. To induce
sustained contractions, carbachol (1 μM) and high K+
(80 mM) were used and the bronchodilator activity was
studied by adding plant extract in a cumulative manner.
Isometric responses were obtained with the help of Bio-
Science transducers and recorded through PowerLab
data acquisition system [30].
Guinea-pig atria
Right atrium from the healthy guinea-pig was dissected
out, cleaned off fatty tissues and mounted in a 15 ml tis-
sue bath containing Kreb’s solution aerated with carbo-
gen at 32°C [31]. The tissue exhibited spontaneous
beating under the resting tension of 1 g due to the pres-
ence of pacemaker cells. An equilibrium period of
30 min was provided before the application of any
chemical substance. This preparation allowed us to study
the effect of the test substance on both rate and force of
spontaneous atrial contractions. The data obtained rep-
resent the force of atrial contractions, while rate of atrial
contractions was obtained by increasing speed of the
chart. The control responses of isoprenaline (1 μM) were
obtained at least in duplicate. Isometric responses were
obtained with the help of BioScience transducers and
recorded through PowerLab data acquisition system.
Statistical analysis
The data are expressed as mean ± standard error of the
mean (S.E.M., n = number of experiments) or the median
effective concentrations (EC50 values) given with 95%
confidence intervals (CI). The statistical parameter ap-
plied is the Student’s t-test and One-way analysis of vari-
ance (ANOVA) followed by Dunnett’s test. P < 0.05 is
considered as significant.
Results
In vivo experiments
Laxative activity
When administered orally, the plant extract showed
laxative effect in mice as reflected by an increase in the
total number of feces (Figure 1). The laxative effect was
mediated at the dose level of 100 and 300 mg/kg and
was 20.5 ± 3.1 and 23 ± 3.0, respectively, as opposed to
7.9 ± 1.3 feces with saline. Carbachol similarly increased
the fecal output to 18.9 ± 1.5 at 10 mg/kg. The laxative
effect of the plant extract was declined with further in-
crease in dose to 500 mg/kg.
Bronchodilator activity
The crude extract of A. spinosus at the doses of 1, 3, 10
and 30 mg/kg caused 15.0 ± 3.0, 32.5 ± 2.5, 44.0 ± 2.0
Figure 1 Laxative effect of various concentrations of crude
extract of A. spinosus (As.Cr) and carbachol (CCh) in healthy
mice. *p< 0.05, **p< 0.01 vs. Saline.
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and 47.5 ± 2.5% (n = 4) respective suppression of
CCh (100 μg/kg)-induced increase in respiratory pres-
sure of anaesthetized rats (Figure 2a). Inhibitory effect of
A. spinosus was comparable to aminophylline, used as a
positive control, which inhibited the CCh-mediated
bronchoconstriction at similar doses by 13.3 ± 5.8, 30.5
± 4.5, 42.8 ± 10.6 and 54.1 ± 5.2% (n = 4), respectively
(Figure 2b).
In vitro experiments
Effect on rabbit jejunum
In spontaneously contracting rabbit jejunum prepara-
tions, the crude extract of A. spinosus showed a
concentration-dependent (0.3-10 mg/ml) spasmogenic
effect, which did not sustain and was subsequently
followed by relaxation when the tissue was left un-
washed for some time (Figure 3a). The spontaneous
contractions of the tissue were fully revived
after washing with Tyrode’s solution and the spas
mogenic effect was reproducible. The spasmogenic
effect, measured as % of ACh (3.0 μM)-induced max-
imum response was 0.57 ± 0.26, 1.1 ± 0.32, 3.60 ± 0.92,
9.02 ± 2.24, 21.00 ± 4.09, 44.39 ± 5.22, 72.57 ± 7.55 and
99.16 ± 6.14 (mean ± S.E.M., n = 4) at the respective
concentrations of 0.01, 0.03, 0.1, 0.3, 1.0, 3.0, 5.0 and
10.0 mg/ml. Pre-treatment of the tissues with atro-
pine (0.1 μM) partially suppressed the spasmogenic
effect of the plant extract (Figure 3a). The plant ex-
tract also relaxed high K+ and CCh (1 μM)-induced
contractions (Figure 3a) with respective EC50 value of
0.31 (0.22-0.46, 95% CI, n = 5) and 2.3 mg/ml (0.17-
2.61, n = 5), similar to diltiazem, which relaxed spon-
taneous, high K+ and CCh-induced contractions with
respective EC50 values of 0.69 (0.58-0.83, n = 3), 0.09
(0.07-0.11, n = 4) and 0.63 mg/ml (0.56-0.72, n = 4)
(Figure 3b). The relaxant effect of both the plant ex-
tract and diltiazem against CCh-induced contraction
was not affected by pretreatment of the tissues with
propranolol (1 μM), however, pretreatment of tissue
with the crude extract of A. spinosus shifted the Ca++
concentration-response curves (CRCs) rightwards in a
concentration-dependent manner (0.03-0.3) similar to
diltiazem (0.03 and 0.1 μM), as shown in Figure 4a
and b, respectively.
Effect on guinea-pig ileum
The crude extract of A. spinosus caused a concentration-
dependent (0.01-10 mg/ml) spasmogenic effect in iso-
lated guinea-pig ileum (Figure 5). The spasmogenic ef-
fect, measured as % of ACh (1 μM)-induced maximum
contraction, was 4.89 ± 2.29, 12.99 ± 4.07, 24.21 ± 1.85,
34.29 ± 5.89, 46.87 ± 8.00, 73.65 ± 12.09, 94.61 ± 5.20, and
94.41 ± 5.10 (n = 4) at the respective concentration of
0.01, 0.03, 0.1, 0.3, 1, 3, 5, and 10 mg/ml, showing
maximum response to that of ACh. The spasmogenic ef-
fect of crude extract was partially suppressed in tissues
pre-treated with atropine (0.1 μM) as shown in Figure 5.
Figure 2 Dose-dependent inhibitory effect of (a) the crude
extract of A. spinosus (As.Cr) and (b) aminophylline on
carbachol (CCh)-induced bronchoconstriction in anaesthetized
rats. Values shown are mean ± S.E.M, n = 4–6, *P< 0.05, **P< 0.01,
***P< 0.001 vs. control (CCh), One-way ANOVA, followed by
Dunnett’s test.
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Effect on rabbit trachea
When tested on isolated rabbit trachea, the plant extract
inhibited K+ (80 mM) and CCh (1 μM)-induced contrac-
tions (Figure 6a) with respective EC50 values of 0.24 mg/ml
(0.18-0.30, n=5) and 0.15 mg/ml (0.10-0.22, n=5). Pretreat-
ment of the tissues with propranolol (1 μM) cause a right-
ward shift in the inhibitory CRCs of the plant extract
constructed against CCh-induced contraction with resultant
EC50 value of 3.23 mg/ml (2.51-4.15, n=4). Diltiazem inhib-
ited high K+ and CCh (1 μM)-induced contractions with
EC50 values of 0.22 mg/ml (0.14-0.39, n=4) and 0.72 mg/ml
(0.52-1.0, n=4), respectively (Figure 6b), but the relaxant ef-
fect of diltiazem was not affected by the presence of pro-
pranolol. When tested on Ca++ curves, the plant extract
concentration-dependently (0.01-0.1 mg/ml), shifted Ca++
CRCs towards right similar to diltiazem (0.1 and 0.3 μM),
as shown in Figure 7a and b, respectively.
Figure 3 Concentration-dependent effect of (a) the crude
extract of A. spinosus (As.Cr) and (b) diltiazem on spontaneous,
K+ and carbachol (CCh)-induced contractions in isolated rabbit
jejunum. The stimulant effect of As.Cr on spontaneous contraction
is taken in the absence and presence of atropine (0.1 μM), while the
inhibitory effect of both As.Cr and diltiazem against CCh-induced
contractions is taken in the absence and presence of propranolol
(Prop., 1 μM). Values shown are mean± S.E.M., n = 3–5.
Figure 4 Concentration-response curves of Ca++ in the absence
and presence of (a) the crude extract of A. spinosus (As.Cr) and
(b) diltiazem in isolated rabbit jejunum. Values are expressed as
mean± S.E.M., n = 4.
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Effect on guinea-pig atria
When tested on spontaneously beating guinea-pig atria,
the crude extract of A. spinosus increased both force and
rate of contraction at 0.01-0.3 mg/ml, similar to isopren-
aline (0.01-1 μM), as shown in Figure 8. With further in-
crease in concentrations, the plant extract did not cause
further increase in cardiac contractility (Figure 8a). The
cardio-stimulant effect of the plant extract was inhibited
in the tissues pre-treated with propranolol (1 μM) as
shown in Figure 8a. The effect on heart rate was found
blunt at lower concentration (0.01-0.3 mg/ml), while
dose-dependent inhibitory effect was observed at higher
concentrations (1.0-5.0 mg/ml). Similar to the inotropic
effect, the chronotropic effect was also inhibited in the
presence of propranolol (Figure 8b). Similarly, the cardi-
ostimulant effect of isoprenaline (0.01-0.3 μM) both on
force and rate of contraction were shifted towards right
when reproduced in the tissues pretreated with propran-
olol (Figure 8c and d).
Effect of fractions on rabbit jejunum
The ethyl acetate fraction of the crude extract of A.
spinosus (As.EtAc) was found devoid of stimulant effect
and exhibited concentration-dependent relaxant effect on
spontaneous and high K+ (80 mM)-induced contractions
with EC50 values of 0.48 mg/ml (0.37-0.63, n = 4) and
0.27 mg/ml (0.19-0.38, n = 4), respectively (Figure 9a).
The aqueous fraction (As.Aq) produced a concentration-
dependent spasmogenic effect at 0.01-10.0 mg/ml (Figure 9b)
with maximum spasmogenic effect of 96.28±8.10% ; (n=5)
close to ACh-induced maximum response (P>0.05), fol-
lowed by relaxation when tissue was left unwashed for some
time and showed weak inhibitory effect on K+ (80 mM)-
induced contraction.
Discussion
In view of its medicinal use in gastrointestinal and air-
ways disorders, the crude extract of A. spinosus was
Figure 5 Bar-chart showing the concentration-dependent
spasmogenic effect of the crude extract of A. spinosus (As.Cr)
in the absence and presence of atropine (0.1 μM) in isolated
guinea-pig ileum. The responses are shown as % of Ach
(1 μM)-induced maximum contractile effect. Values are given as
mean± S.E.M., n = 4–5.
Figure 6 Concentration-dependent relaxation effects of (a) the
crude extract of A. spinosus (As.Cr) and (b) diltiazem on K+ and
CCh-induced contractions in isolated rabbit trachea. Effect of As.
Cr on CCh-induced contraction is recorded in the presence and
absence of propranolol (prop). Values are shown as mean± S.E.M.,
n = 3–6.
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subjected to pharmacological investigation in order to
validate the medicinal uses and explore possible under-
lying mechanisms.
To observe its laxative effect, the plant extract was
administered orally to healthy mice, which produced a
dose-dependent laxation at 100 and 300 mg/kg, similar
to carbachol (1 mg/kg). A further increment in dose
(500 mg/kg) decreased the fecal output possibly due to
the presence of spasmolytic component along with spas-
mogenic constituents. In addition, there are multiple
reports showing the safety of plant administration in
experimental animals at around 4 times higher doses
than the highest dose tested in this study [32,33].
To explore the possible mechanism possibly under-
lying its laxative effect, the crude extract was tested on
spontaneously contracting rabbit jejunum, where it
showed a concentration-dependent spasmogenic effect
followed by relaxation when the tissue was left un-
washed for some time. The spontaneous movement of
intestine is regulated by periodic depolarization and
re-polarization and the peak of depolarization is repre-
sented by action potential generated due to the rapid in-
flux of Ca++ via voltage dependant L-type Ca++ channels
(VDLCs) [34]. Maximum spasmogenic effect of the
crude extract was found similar to ACh-induced max-
imum contractile response suggesting the high efficacy
of its spasmogenic effect. To see if the gut stimulant ef-
fect was mediated through cholinergic activity, the
stimulant effect was challenged by atropine (0.1 μM), a
known muscarinic receptor antagonist [35]. In the pres-
ence of atropine, the contractile effect of the extract was
partly blocked, indicating the presence of cholinergic
constituent(s) and some additional mechanism(s) re-
sponsible for the observed stimulant effect. The use of
the specific antagonists also ruled out the possible pres-
ence of any histaminergic, serotonergic or nicotinic ac-
tivity in the crude extract of A. spinosus mediating its
spasmogenic effect (data not shown).
The gut stimulant effect of the crude extract was fur-
ther studied on guinea-pig ileum, a quiescent prepar-
ation considered useful for this purpose [29]. The plant
extract exhibited dose dependent contractions in guinea-
pig ileum partly suppressed by atropine, a similar pattern
of activity was observed in jejunum thus confirming the
involvement of more than one pathway in the spasmodic
effect of the plant extract. Results of this study indicate
the presence of spasmogenic constituents in the plant
that may account for its medicinal use in constipation
and also invite further experimental work to explore the
exact nature of additional spasmogenic component.
The spasmogenic effect in gut preparations was followed
by spontaneous relaxation when the tissues were left un-
washed for some time, indicating the presence of spasmo-
lytic component in combination with spasmogenic activity.
In our previous studies we have noticed the presence of Ca
++ channel blocking activity in plants as mechanism usually
underlying their spasmolytic effect [30,36,37]. To see,
whether the relaxant effect of A. spinosus is mediated
through the same mechanism, the tissue was pretreated
with high K+ (80 mM), which produced a sustained con-
traction. The contractile response induced by high concen-
tration of K+ (80 mM) is due to release and influx of
extracellular Ca++ through L-type voltage-sensitive chan-
nels [37]. The plant extract completely relaxed the K+
(80 mM)-induced contraction in isolated rabbit jejunum
Figure 7 Concentration-response curves of Ca++ in the absence
and presence of (a) the crude extract of A. spinosus (As.Cr) and
(b) diltiazem in isolated rabbit trachea. Values are expressed as
mean± S.E.M., n = 3–5.
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indicating the Ca++ channel blocking activity. The presence
of CCB activity in A. spinosus was further strengthened
when the plant extract shifted the Ca++ CRCs towards
right, similar to diltiazem, a standard Ca++ channel blocker
[38]. The presence of spasmolytic activity in the plant
mediated through CCB mechanism may be responsible
for its medicinal use in abdominal colic and perhaps also
meant by nature to offset the excessive gut stimulant ac-
tion that is usually observed with chemical drugs.
The plant material has traditionally been used for
the management of respiratory diseases like asthma
and bronchitis. To see the possible bronchodilator activity,
the crude extract was tested on CCh-induced broncho-
spasm in anesthetized rats, where it caused a dose-
dependent inhibition of CCh-induced bronchoconstriction,
similar to aminophylline, a known bronchodilator agent
[39]. To further explore the possible mechanism in its
bronchodilator activity, the plant extract was tested on
rabbit tracheal preparations precontracted with high K+
or CCh. The crude extract completely relaxed high K+
and CCh-induced contractions at similar concentration,
whereas, diltiazem was more potent against K+ induced
contraction, a typical characteristic of a pure CCB [40].
The CCB component in A. spinosus was confirmed when
it shifted the Ca++ CRCs constructed in rabbit trachea to-
wards right, similar to diltiazem. The Ca++ channel block-
ers have been found to be useful in bronchospastic
disorders [40,41]. To see, if the bronchodilator effect of the
crude extract was mediated through β2-agonist activity, in-
hibitory effect of the plant extract on CCh-induced spasms
was tested in the presence of propranolol (1 μM), a non-
specific β–adrenergic receptor antagonist [42]. In the pres-
ence of propranolol, the relaxant effect of A. spinosus ex-
tract on CCh-induced contraction was observed at
significantly higher concentration, indicating the presence
of β–adrenergic activity. The β2–adrenergic agonists are
widely used in clinical practice as bronchodilator agents
[42].
Figure 8 Effect of (a and b) the crude extract of A. spinosus (As.Cr) and (c and d) isoprenaline in the absence and presence of
propranolol (Prop.,1μM) on force and rate of spontaneous contractions of isolated guinea-pig right atria. Values are shown as mean±
S.E.M., n = 3–5.
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Interestingly, the crude extract of A. spinosus increased
force of contraction followed by relaxation at the higher
concentration. The cardio-tonic effect was diminished in
tissues pretreated with propranolol and the relaxant
effect became more prominent. The cardio-stimulant ef-
fect of adrenergic drugs is mediated through β1-
adrenergic receptors, whereas is bronchodilator effect
through β2 adrenergic receptors [42]. Presence of a com-
bination of cardio-stimulant and bronchodilator activity,
suppressed by propranolol, confirmed the presence of
non-specific β-adrenergic agonist activity similar to
that of isoprenaline. Isoprenaline, though very effective
bronchodilator, but has limited clinical use due to asso-
ciated cardiac stimulation as side-effect [42]. Interest-
ingly, when tested on heart, there was mild ionotropic
effect but no significant increase was observed on hear
rate at low dose, while inhibitory effect was observed
at higher doses. This is perhaps because of co-existence
of cardiac stimulant (β1) and cardiac depressant activity
due to CCB constituents, which has opposing effect
in the heart, while additive and/or synergistic interac-
tions with bronchodilator activity, a desired effect in air
ways disorders. The β-adrenergic activity of A. spinosus
was not seen in jejunal preparations that may be due
to the cardiac and bronchial tissue selectivity of
β-adrenergic effect.
Activity-directed fractionation revealed that the spas-
molytic effect of the crude extract of A. spinosus was
mainly concentrated in the ethyl acetate fraction which
caused inhibition of spontaneous as well as K+-induced
contraction, whereas the spasmogenic effect was con-
centrated in the aqueous fraction along with a weak
spasmolytic activity. This pattern of separating biological
activities among the fractions is in accordance with our
previous findings, that the spasmogenic activity of crude
plant extracts is usually concentrated in the aqueous
fractions while the spasmolytic component is concen-
trated in organic fractions [43,44]. We also speculate
that the spasmogenic component of the plant may not
get absorbed systemically due to its polar nature as
reflected by its water solubility and would not be able to
interfere with its bronchodilator activity.
Conclusion
These data, suggesting the presence of laxative effect in
the plant mediated partly through cholinergic action, spas-
molytic effect through CCB activity and bronchodilator
activity through a combination of CCB and β-agonistic ac-
tivities, explain the medicinal use of A. spinosus in consti-
pation, abdominal colic and airways disorders. Such
coexistence of β-agonist activity with CCB constituents
offers synergistic and side-effect neutralizing potential, a
typical characteristic of natural products [45].
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